A parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA
A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L-DOPA A phase III parallel group comparison study of HP-3000 in patients with Parkinson's disease using L- ...
Parkinson's disease
Intervention name : HP-3000 (ropinirole hydrochloride patch) Dosage And administration of the intervention : Transdermal, once daily Control intervention name : HP-3000 placebo Dosage And administration of the control intervention : Transdermal, once daily Control intervention name : Ropinirole hydrochloride extended-release tablet Dosage And administration of the control intervention : Oral, once daily Control intervention name : Ropinirole hydrochloride extended-release tablet placebo Dosage And administration of the control intervention : Oral, once daily Intervention name : HP-3000 (ropinirole hydrochloride patch) Dosage And administration of the interve ...
Phase II clinical study in patients with Parkinson's disease.
Pharmacokinetic study of HP-3000 in patients with Parkinson's disease.
Parkinson's disease
Intervention name : HP-3000 (ropinirole hydrochloride patch) Dosage And administration of the intervention : Transdermal, once daily Intervention name : HP-3000 (ropinirole hydrochloride patch) Dosage And administration of the interve ...